Renata Pharma

Renata’s Mirpur facility earns Bangladesh’s first EU GMP
Stocks

Renata’s Mirpur facility earns Bangladesh’s first EU GMP

Renata earns EU GMP certification, eyes expansion in global markets
Stocks

Renata earns EU GMP certification, eyes expansion in global markets

Renata’s manufacturing standards win european recognition
Corporates

Renata’s manufacturing standards win european recognition

Renata PLC expands global reach with UK launch of Cabergoline
Corporates

Renata PLC expands global reach with UK launch of Cabergoline

Renata sets preference shares conversion at Tk475 each
Stocks

Renata sets preference shares conversion at Tk475 each

Renata to issue Tk325cr preference shares
Stocks

Renata to issue Tk325cr preference shares

Infographic: TBS
Stocks

Renata's revenue, profit surged by 14%, 55% in FY24

Renata's Cabergoline 0.5mg tablets received approval from the EU Decentralized Procedure (DCP). The medicine is sold in Bangladesh under the name Cabolin. Photo: Collected
Health

Renata can now export drug for Parkinson's disease to Europe

Renata set to pay off short-term loans with bond finance
Stocks

Renata set to pay off short-term loans with bond finance

Renata wants to bring the Moderna vaccine to Bangladesh
Bangladesh

Renata wants to bring the Moderna vaccine to Bangladesh

Renata’s sales jump amid pandemic
Pharma

Renata’s sales jump amid pandemic